Downgrades Outperform Mkt Perform X

GBIO Generation Bio

TD Cowen

Initiated Buy X

GBIO Generation Bio

Canaccord Genuity

$9

Initiated Mkt Outperform X

GBIO Generation Bio

JMP Securities

$40

Initiated Outperform X

GBIO Generation Bio

William Blair

Initiated Buy X

GBIO Generation Bio

Needham

$50

GBIO  Generation Bio Co

Generation Bio Co., a genetic medicines company, develops gene therapies for the treatment of rare and prevalent diseases. The company is developing a portfolio of programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017. Generation Bio Co. was founded in 2016 and is headquartered in Cambridge, Massachusetts.